RxDoctor Payments Data

Young Lee, MD

Interventional Pain Medicine · Hammonton, NJNPI 1609068659

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.1% of the total across 41 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 23.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $819 and has fallen 95.9% since, to $34 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in NJ, where the typical reported total is $3,760.

$2,178in general payments, 2019–2025

Across 41 payments — averaging $53.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nevro Corp.$521
  • Vertos Medical, Inc.$444
  • GRT US Holding, Inc.$213
  • Si-bone, Inc.$173
  • International Rehabilitative Sciences, Inc$147
  • Painteq LLC$132
  • plus $547 from 18 others

What the payments were for

  • Speaking & faculty fees$151%
  • Travel & lodging$60%
  • Food & beverage$2,15799%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,178 in reported general payments places this provider in the 35th percentile of 82 interventional pain medicine providers in New Jersey.

See all interventional pain medicine providers in New Jersey

Medicare billing

Part B allowed, 2024
$286,992
Medicare patients
700
Services billed
7,161

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lidocaine26$5,930
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen329$5,846
OxycontinOxycodone Hcl13$5,783
Oxycodone Hcl190$3,109
Gabapentin109$1,068
Cyclobenzaprine Hcl104$995
Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine12$841
Tramadol Hcl177$831
Tizanidine Hcl66$784
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen42$579
Pregabalin20$524
Ibuprofen52$363
Naproxen29$231
Acetaminophen-CodeineAcetaminophen With Codeine20$229
Methylprednisolone31$136

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Hammonton

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →